Name: X-Posts by @bryan_johnson (machine-readable)
License: https://creativecommons.org/licenses/by/4.0/

Bryan Johnson @bryan_johnson

5/ Slowing Cognitive Decline in Mild-to-Moderate Alzheimer's Disease:

A randomized placebo-controlled trial with 321 participants with mild-to-moderate Alzheimer's disease found that 138 mg/day of methylene blue:

+ Improved performance on the Alzheimer's Disease Assessment